Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNexteq Regulatory News (NXQ)

Share Price Information for Nexteq (NXQ)

Share Price is delayed by 15 minutes
Get Live Data
53.50    0.00 (0.00%)
Bid:
52.00
Ask:
55.00
Spread: 3.00 (5.769%)
Market Cap: £28.98m
NXQ Live PriceLast checked at - London Stock Exchange

Intraday Nexteq Share Chart

AGM Statement

29 Apr 2025 07:00

RNS Number : 5052G
Nexteq PLC
29 April 2025
 

29 April 2025

 

Nexteq plc

 

("Nexteq, the "Company" or the "Group")

 

AGM Statement

 

The Annual General Meeting ("AGM") of Nexteq plc (AIM: NXQ), a leading technology solutions provider to customers in selected industrial markets, will be held today at 10:00am at the Group's offices at The Galleria, Station Road, Crawley, RH10 1WW.

 

At the AGM, Nexteq Chair, Carol Thompson, will make the following statement:

 

"The Board remains confident in achieving 2025 full year market expectations1. Despite the global uncertainty relating to the introductions of tariffs, we have a strong track record managing our supply chain and we are working tirelessly with suppliers and customers to navigate any potential disruption that may arise.

 

"The Board is committed to the Group's three-year plan as presented at the Capital Markets Day in February 2025, including our plans to deliver meaningful organic growth through a renewed focus on innovation and a more diversified business model.

 

"Meanwhile, margin performance remains as expected, and our objective to refocus resources to deliver the three-year plan, as well as operational synergies, is progressing as planned.

 

"As has historically been the case, we have generated positive cashflow, additive to our healthy cash balances and debt free position. This provides a robust foundation to trade through the uncertainty and invest for the future. Our net cash position is $30.2m at 31st March 2025.

 

"The business is well positioned to deliver the objectives of the three-year plan, which includes the creation of innovative new software and hardware products and services across new sectors and geographies."

 

1 Current consensus is $85.5m revenue, $6.0m adjusted EBITDA and $3.6m adjusted PBT

 

Nexteq PLC

Duncan Faithfull, Chief Executive Officer

Matt Staight, Chief Financial Officer

 

Telephone: +44 (0)20 3597 6800

Nominated Adviser and Broker:

Cavendish Capital Markets Ltd

Matt Goode / Edward Whiley (Corporate Finance)

Tim Redfern / Harriet Ward (Corporate Broking)

 

 

 

 

 

Telephone: +44 (0)20 7220 0500

Financial PR:

Alma Strategic Communications

Hilary Buchanan / Emma Thompson

 

Telephone: +44 (0)20 3405 0205

 

About Nexteq

Nexteq (AIM: NXQ) is a strategic technology solutions provider to customers in selected industrial markets. Its innovative technology enables the manufacturers of global electronic equipment to outsource the design, development and supply of non-core aspects of their product offering. By outsourcing elements of their technology stack to Nexteq, customers can focus their product development effort on the most critical drivers of their business' success.

 

Our solutions are delivered through a global sales team and leverage the Group's electronic hardware, software, display and mechanical engineering expertise. Our Taiwan operation is at the heart of Asian supply networks and facilitates cost effective manufacturing and strategic supply chain management.

 

The Group operates in six countries and services over 500 customers across 47 countries.

 

Nexteq operates two distinct brands: Quixant, a specialised computer platforms provider, and Densitron, leaders in human machine interface technology, each with dedicated sales, account management and product innovation teams. Founded in 2005, and later floating on the London Stock Exchange's AIM stock market as Quixant plc, the Group rebranded to Nexteq in 2023.

 

Further information on Nexteq and its divisions can be found at www.nexteqplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEMESAEISEFL
Date   Source Headline
13th Oct 20254:31 pmRNSNotification of major holdings
18th Sep 202511:45 amRNSResult of General Meeting
17th Sep 20257:00 amRNSFirst Mass Production Purchase Order for Brazil
10th Sep 20259:15 amRNSNotification of major holdings
10th Sep 20259:15 amRNSNotification of major holdings
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSShare Buyback, Rule 9 Waiver, Notice of GM
20th Aug 20257:00 amRNSNotice of Investor Presentation
22nd Jul 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNS-RProDeck wins Best of Show award at NAB Show 2025
7th May 202512:43 pmRNSGrant of Options
29th Apr 20252:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Statement
3rd Apr 202510:41 amRNSReport and Accounts and Notice of AGM
3rd Apr 20257:00 amRNSDirector Shareholding
2nd Apr 20257:00 amRNSChair Appointment
31st Mar 202510:17 amRNSChange of Registered Office
19th Mar 20257:00 amRNSFinal Results
14th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20258:37 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20257:00 amRNSNotice of Investor Presentation
11th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20257:00 amRNSCapital Markets Event
25th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting
21st Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 202510:45 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 202511:51 amRNSNotification of major holdings
22nd Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20257:00 amRNSTrading Update and Notice of Results
14th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jan 20257:00 amRNSHolding(s) in Company
6th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.